Search
AtriCure Inc
ATRCAdd to Watchlist
31.345USD
+1.615+5.43%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.56BMarket Cap
LossP/E TTM
More Details of AtriCure Inc Company
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
AtriCure Inc Info
Ticker SymbolATRC
Company nameAtriCure Inc
IPO dateAug 05, 2005
CEOCarrel (Michael H)
Number of employees1300
Security typeOrdinary Share
Fiscal year-endAug 05
Address7555 Innovation Way
CityMASON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code45040
Phone15137554100
Websitehttps://www.atricure.com
Ticker SymbolATRC
IPO dateAug 05, 2005
CEOCarrel (Michael H)
Company Executives of AtriCure Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
FAQs
Who are the top five shareholders of AtriCure Inc?
The top five shareholders of AtriCure Inc are: Mr. Michael H. (Mike) Carrel, CPA
How many institutions hold shares of AtriCure Inc (ATRC)?
As of 2026Q1, 505 institutions hold shares of AtriCure Inc, with a combined market value of approximately 48.18M, accounting for 95.14% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -7010307.00.
What is the biggest source of revenue for AtriCure Inc?
In 2026Q1, the Appendage Management-United states business generated the highest revenue for AtriCure Inc, amounting to 178.13M and accounting for 33.32% of total revenue.